QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
OTCMKTS:LBTSF

Almirall - LBTSF Stock Forecast, Price & News

$9.68
0.00 (0.00%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.68
$9.68
50-Day Range
$9.28
$9.68
52-Week Range
$9.28
$9.68
Volume
N/A
Average Volume
383 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.50
LBTSF stock logo

About Almirall (OTCMKTS:LBTSF) Stock

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Receive LBTSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Almirall and its competitors with MarketBeat's FREE daily newsletter.

LBTSF Stock News Headlines

Almirall, S.A. reports Q1 results
Here's what Wall Street expects from Almirall's earnings
Almirall reports FY results
See More Headlines
Receive LBTSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Almirall and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:LBTSF
CIK
N/A
Fax
N/A
Employees
1,786
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.50
High Stock Price Forecast
$13.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+18.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Gianfranco Nazzi (Age 53)
    CEO & Exec. Director
  • Mr. Michael McClellan (Age 50)
    Exec. VP of Fin., CFO & Member of Management Board
  • Mr. Joan Figueras Carreras
    Vice Sec., Member of Mgmt. Board, Non-Voting Director & Exec. Director of Corp. Governance
  • Mr. Eloi Crespo Cervera
    Sr. VP of Industrial Operations & Member of Management Board
  • Mr. Jordi Sabé Richer
    Sr. VP of Corp. Devel. & Member of Management Board
  • Mr. Esteve Conesa Panicot
    Sr. VP of HR & Member of Management Board
  • Dr. Volker Koscielny
    Chief Medical Officer & Member of Management Board
  • Mr. Pablo Alvarez
    Member of Management Board, Pres of Almirall US & GM of Almirall US
  • Dr. Karl Ziegelbauer
    Exec. VP of R&D, CSO and Member of Management Board
  • Mr. Paolo Cionini
    Chief Commercial Officer Europe & International and Member of Management Board













LBTSF Stock - Frequently Asked Questions

Should I buy or sell Almirall stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Almirall in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LBTSF shares.
View LBTSF analyst ratings
or view top-rated stocks.

What is Almirall's stock price forecast for 2023?

4 analysts have issued 12 month price targets for Almirall's stock. Their LBTSF share price forecasts range from $10.00 to $13.00. On average, they expect the company's share price to reach $11.50 in the next twelve months. This suggests a possible upside of 18.8% from the stock's current price.
View analysts price targets for LBTSF
or view top-rated stocks among Wall Street analysts.

How have LBTSF shares performed in 2022?

Almirall's stock was trading at $12.10 at the beginning of 2022. Since then, LBTSF stock has decreased by 20.0% and is now trading at $9.68.
View the best growth stocks for 2022 here
.

Are investors shorting Almirall?

Almirall saw a increase in short interest in November. As of November 15th, there was short interest totaling 338,200 shares, an increase of 16.3% from the October 31st total of 290,800 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.
View Almirall's Short Interest
.

What is Almirall's stock symbol?

Almirall trades on the OTCMKTS under the ticker symbol "LBTSF."

How do I buy shares of Almirall?

Shares of LBTSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Almirall's stock price today?

One share of LBTSF stock can currently be purchased for approximately $9.68.

How many employees does Almirall have?

The company employs 1,786 workers across the globe.

How can I contact Almirall?

Almirall's mailing address is Ronda General Mitre, 151, Barcelona, Catalonia 08022. The official website for the company is www.almirall.com. The company can be reached via phone at 34 93 291 30 00.

This page (OTCMKTS:LBTSF) was last updated on 12/8/2022 by MarketBeat.com Staff